DKC1 and dyskeratosis congenita: Subsequently, it was shown that the phenotype of a mouse model carrying DKC1-inactivating mutations found in human dyskeratosis congenita was dependent on the decreased modification of 28S rRNA and the aberrant translation of oncogenic and tumour-suppressive mRNAs, including VEGF and p53 [42] (Table 1).